Using a nationwide sample of insurance claims, researchers found that large declines occurred in contraceptive visits in the first month of the COVID-19 pandemic (April 2020 compared to May 2019). Although visit numbers improved over time, they remained below pre-pandemic levels through the end of 2020.
With the increasing circulation of the Delta variant, it has become critically important for the OB/GYN to discuss COVID-19 vaccination with patients, and, specifically, to address concerns related to pregnancy, lactation, and fertility. This article reviews the most recent guidance from the American College of Obstetricians and Gynecologists, the Society of Maternal-Fetal Medicine, and the American Society for Reproductive Medicine on vaccination in reproductive-age individuals.
Researchers studied more than 1,000 women, ages 18 and 19 years, over several years, asking them weekly questions about their contraceptive use, sex, and pregnancy. They found that women who experience material hardship use contraceptives less consistently.
Researchers found neither low levels of high-density lipoprotein nor high levels of low-density lipoprotein were associated with predicted survival in older women. This finding is consistent with other studies of cholesterol and mortality in the elderly.
Researchers at the Baltimore-based Johns Hopkins University say an online “pop quiz” they developed in 2009 shows promising accuracy in predicting sexually transmitted infections in young women, although not apparently in young men.
Epilepsy is common, affecting 2.2 million Americans, of which approximately half are women of reproductive age.1 The Association of Reproductive Health Professionals has just released a webinar, “Women with Nerve: Providing Reproductive Health Care for Women with Epilepsy,” to help providers review evidence-based information on the subject.